Kidney Function Stable During 12 Months of Pegloticase-Methotrexate for Gout
Gout is a risk factor for CKD progression, so investigators probed the effect of pegloticase-methotrexate treatment on kidney function.
Source: empr.com
Increase Response Rates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Increase Response Rates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Increase Response Rates Today - Breaking & Trending Today
Kidney Function Stable During 12 Months of Pegloticase-Methotrexate for Gout
Gout is a risk factor for CKD progression, so investigators probed the effect of pegloticase-methotrexate treatment on kidney function.
Source: renalandurologynews.com
Pegloticase Combined With Methotrexate Maintains Efficacy for Gout at Year 1
Pegloticase combined with methotrexate leads to a better drug response with less infusion reaction among patients with uncontrolled gout.
Source: clinicaladvisor.com
Pegloticase Combined With Methotrexate Maintains Efficacy for Gout at Year 1
At month 12, 60.0% of the MTX group and 30.8% of the placebo group achieved treatment response.
Source: empr.com
Horizon Therapeutics plc: Sustained Patient Response to KRYSTEXXA (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled Trial
-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 -- -- Imaging
Source: finanznachrichten.de